NEW YORK – Siemens Healthineers has been granted funding from the Gates Foundation to support development of a maternal health screening tool, the firm announced on Friday. The total amount of the ...

The Spanish company will use the funding to accelerate the clinical transition of its LiverAce Combo assay for drug-induced liver injury assessment.

Altai Capital said last month it had "serious concerns about the company’s significant share price underperformance." ...

In a presentation, executives discussed upcoming data readouts and their potential effect on reimbursement for the firm's FirstLook Lung test.

NEW YORK — Several Delta Dental dental health plan administrators said on Thursday that they will begin coverage of OraLiva's oral cancer test.

Chairman and CEO Adam Schechter said that deals may open up as hospital systems grow concerned about Medicaid cuts and the end of Affordable Care Act subsidies.

The CitoCBC system received FDA 510(k) clearance and CLIA waiver almost a year ago and provides results in about eight minutes in near-patient settings.

Diagnostics is already operating somewhat separately from the firm's other two business units under its new organizational structure, company officials said.

The bill was one of several discussed during a Thursday hearing by the Health Subcommittee of the House of Representatives' ...

NEW YORK — Point-of-care testing firm Truvian Health said on Monday that nine tests that run on its TruVerus benchtop blood analyzer have received 510(k) clearances from the US Food and Drug ...

President and CEO Jim Davis said he believes PAMA reform will pass this year but said another temporary delay will likely be needed to postpone cuts slated for February 1.

The company said its preliminary revenue for the fourth quarter was at least $21 million, and its full-year 2025 revenue is expected to grow to $77 million.